Literature DB >> 189045

Transient virus expression during murine leukemia induction by X-irradiation.

M Haas.   

Abstract

Most X-irradiation-induced thymomas in C57BL/6 mice are virus-free when assayed by immunofluorescence for the gs antigen (gsa) of murine leukemia virus (MuLV). Virus was induced transiently in bone marrow cells and later appeared in thymus cells. Six to 7 weeks post irradiation, thymocytes and bone marrow cells were MuLV gsa-negative and remained negative for the lifetime of most animals, whether or not they contracted overt leukemia. During the period when MuLV gsa-positive bone marrow cells were found, XC-positive syncytia-producing bone marrow cells were also found. Virus information was expressed, therefore, for a limited duration, long before any signs of leukemia in the animals were evident. MuLV gsa-positive thymocytes taken from mice 4 weeks after X-irradiation were cocultivated with a series of indicator cells. B-tropic virus, in addition to a xenotropic virus, was isolated from these cells. Ecotropic virus was not found in normal mouse thymocytes, in irradiated thymocytes a few days after termination of the X-irradiation sequence, or in most primary thymomas. All thymocytes produced only xenotropic virus in the cocultivation assays. Expression of the ecotropic virus was, therefore, transient, as assayed by immunofluorescence, XC syncytia formation, and virus isolation from MuLV gsa-positive thymus cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189045     DOI: 10.1093/jnci/58.2.251

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Leukemogenic activity of thymotropic, ecotropic, and xenotropic radiation leukemia virus isolates.

Authors:  M Haas
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

2.  Involvement of mouse mammary tumor virus in spontaneous and hormone-induced mammary tumors in low-mammary-tumor mouse strains.

Authors:  R Michalides; L van Deemter; R Nusse; G Röpcke; L Boot
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

3.  Activation of endogenous C-type retroviral genomes by internal alpha-irradiation of mice with 224Radium.

Authors:  J Schmidt; V Erfle; W A Müller
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

4.  Studies on emerging radiation leukemia virus variants in C57BL/Ka mice.

Authors:  E Rassart; M Shang; Y Boie; P Jolicoeur
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

5.  Frequent isolation of ecotropic murine leukemia virus after x-ray irradiation of C57BL/6 mice and establishment of producer lymphoid cell lines from radiation-induced lymphomas.

Authors:  P Sankar-Mistry; P Jolicoeur
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

6.  Abrogation of radiation leukemia virus-induced lymphomagenesis by antisera to thymotropic but not to ecotropic or dual-tropic viruses.

Authors:  M Haas; J Jongstra
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  In vitro generation of cytotoxic lymphocytes against radiation and radiation leukaemia virus-induced tumours. II. A radiation-induced thymoma generates cytyotoxic response in syngeneic but not in allogeneic lymphocytes.

Authors:  E Yefenof
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

8.  RNA virus expression during and after methylnitrosourea-induced T-cell leukemogenesis in mice.

Authors:  M Grompe; L Kreja; J Schmidt; H J Seidel
Journal:  Blut       Date:  1985-12

9.  Association of endogenous retroviruses with radiation-induced leukemias of BALB/c mice.

Authors:  R W Ellis; E Stockert; E Fleissner
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

10.  Strong selection for cells containing new ecotropic recombinant murine leukemia virus provirus after propagation of C57BL/6 radiation-induced thymoma cells in vitro or in vivo.

Authors:  P Jolicoeur; E Rassart; P Sankar-Mistry
Journal:  Mol Cell Biol       Date:  1983-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.